Abstract
Oxytocin has recently gained significant attention because of its role in the pathophysiology and management of dominant neuropsychiatric disorders. Oxytocin, a peptide hormone synthesized in the hypothalamus, is released into different brain regions, acting as a neurotransmitter. Receptors for oxytocin are present in many areas of the brain, including the hypothalamus, amygdala, and nucleus accumbens, which have been involved in the pathophysiology of depression, anxiety, schizophrenia, autism, Alzheimer’s disease, Parkinson’s disease, and attention deficit hyperactivity disorder. Animal studies have spotlighted the role of oxytocin in social, behavioral, pair bonding, and mother–infant bonding. Furthermore, oxytocin protects fetal neurons against injury during childbirth and affects various behaviors, assuming its possible neuroprotective characteristics. In this review, we discuss some of the concepts and mechanisms related to the role of oxytocin in the pathophysiology and management of some neuropsychiatric, neurodegenerative, and neurodevelopmental disorders.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ADHD:
-
Attention deficit and hyperactivity disorder
- ASD:
-
Autism spectrum disorder
- BBB:
-
Blood-brain barrier
- CGRP:
-
Calcitonin gene-related peptide
- CREB:
-
The cAMP-responsive element-binding protein
- CSF:
-
Cerebrospinal fluid
- EEG:
-
Electroencephalogram
- eEF2:
-
Eukaryotic elongation factor 2
- eNOS:
-
Endothelial NO synthase
- GPCR:
-
G-protein-coupled receptor
- IN:
-
Intranasal
- iNOS:
-
Inducible nitric oxide synthase
- MAPK:
-
Mitogen-activated protein kinase
- NMDA:
-
N-methyl-D-aspartate
- NO:
-
Nitric oxide
- OT:
-
Oxytocin
- OTR:
-
Oxytocin receptor
- PANSS:
-
Positive and negative symptoms scale
- PD:
-
Parkinson’s disease
- PPD:
-
Postpartum depression
- PTZ:
-
Pentylenetetrazole
- PVN:
-
Paraventricular nuclei
- SCZ:
-
Schizophrenia
- SON:
-
Supraoptic nuclei
References
Alaerts K, Steyaert J et al (2021) Changes in endogenous oxytocin levels after intranasal oxytocin treatment in adult men with autism: an exploratory study with long-term follow-up. Eur Neuropsychopharmacol 43:147–152
Alpern L, Lyons R (1993) Chronicity and timing of maternal depressive symptoms and child behavior problems at school and at home. Dev Psychopathol 5(3):371–387
Anagnostou E, Soorya L et al (2014) Intranasal oxytocin in the treatment of autism spectrum disorders: a review of literature and early safety and efficacy data in youth. Brain Res 1580:188–198
Andari E, Duhamel JR et al (2010) Promoting social behavior with oxytocin in high-functioning autism spectrum disorders. Proc Natl Acad Sci U S A 107(9):4389–4394
Apter-Levy Y, Feldman M et al (2013) Impact of maternal depression across the first 6 years of life on the child’s mental health, social engagement, and empathy: the moderating role of oxytocin. Am J Psychiatr 170(10):1161–1168
Arletti R, Bertolini A (1987) Oxytocin acts as an antidepressant in two animal models of depression. Life Sci 41(14):1725–1730
Armstrong WE (2015) Hypothalamic supraoptic and paraventricular nuclei. The rat nervous system. Academic Press, pp 295–314
Averbeck B, Bobin T et al (2012) Emotion recognition and oxytocin in patients with schizophrenia. Psychol Med 42(2):259–266
Bachmann CG, Trenkwalder C (2006) Body weight in patients with Parkinson’s disease. Mov Disord 21(11):1824–1830
Bakos J, Strbak V et al (2013) Oxytocin receptor ligands induce changes in cytoskeleton in neuroblastoma cells. J Mol Neurosci 50(3):462–468
Bales KL, Perkeybile AM et al (2013) Chronic intranasal oxytocin causes long-term impairments in partner preference formation in male prairie voles. Biol Psychiatry 74(3):180–188
Banks WA (2019) The blood–brain barrier as an endocrine tissue. Nat Rev Endocrinol 15(8):444–455
Bartholomeusz CF, Ganella EP et al (2015) Effects of oxytocin and genetic variants on brain and behaviour: implications for treatment in schizophrenia. Schizophr Res 168(3):614–627
Becker S, Wojtowicz JM (2007) A model of hippocampal neurogenesis in memory and mood disorders. Trends Cogn Sci 11(2):70–76
Bernaerts S, Berra E et al (2016) Influence of oxytocin on emotion recognition from body language: a randomized placebo-controlled trial. Psychoneuroendocrinology 72:182–189
Berry A, Bellisario V et al (2012) Social deprivation stress is a triggering factor for the emergence of anxiety-and depression-like behaviours and leads to reduced brain BDNF levels in C57BL/6J mice. Psychoneuroendocrinology 37(6):762–772
Blume A, Bosch OJ et al (2008) Oxytocin reduces anxiety via ERK1/2 activation: local effect within the rat hypothalamic paraventricular nucleus. Eur J Neurosci 27(8):1947–1956
Boccia M, Petrusz P et al (2013) Immunohistochemical localization of oxytocin receptors in human brain. Neuroscience 253:155–164
Bolay H, Reuter U et al (2002) Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med 8(2):136–142
Bosch OJ, Dabrowska J et al (2016) Oxytocin in the nucleus accumbens shell reverses CRFR2-evoked passive stress-coping after partner loss in monogamous male prairie voles. Psychoneuroendocrinology 64:66–78
Buchheim A, Heinrichs M et al (2009) Oxytocin enhances the experience of attachment security. Psychoneuroendocrinology 34(9):1417–1422
Busnelli M, Saulière A et al (2012) Functional selective oxytocin-derived agonists discriminate between individual G protein family subtypes. J Biol Chem 287(6):3617–3629
Cacciotti-Saija C, Langdon R et al (2015) A double-blind randomized controlled trial of oxytocin nasal spray and social cognition training for young people with early psychosis. Schizophr Bull 41(2):483–493
Calcagnoli F, Stubbendorff C et al (2015) Oxytocin microinjected into the central amygdaloid nuclei exerts anti-aggressive effects in male rats. Neuropharmacology 90:74–81
Caldwell H, Stephens S et al (2009) Oxytocin as a natural antipsychotic: a study using oxytocin knockout mice. Mol Psychiatry 14(2):190–196
Catena-Dell'Osso M, Fagiolini A et al (2013) Non-monoaminergic targets for the development of antidepressants: focus on neuropeptides. Mini-Rev Med Chem 13(1):2–10
Cattaneo M, Chini B et al (2008) Oxytocin stimulates migration and invasion in human endothelial cells. Br J Pharmacol 153(4):728–736
Chini B, Verhage M et al (2017) The action radius of oxytocin release in the mammalian CNS: from single vesicles to behavior. Trends Pharmacol Sci 38(11):982–991
Cho K-O, Lybrand ZR et al (2015) Aberrant hippocampal neurogenesis contributes to epilepsy and associated cognitive decline. Nat Commun 6(1):1–13
Cipriani A, Geddes JR et al (2007) Metareview on short-term effectiveness and safety of antidepressants for depression: an evidence-based approach to inform clinical practice. Can J Psychiatr 52(9):553–562
Clarici A, Pellizzoni S et al (2015) Intranasal adminsitration of oxytocin in postnatal depression: implications for psychodynamic psychotherapy from a randomized double-blind pilot study. Front Psychol 6:426
Davis MC, Lee J et al (2013) Effects of single dose intranasal oxytocin on social cognition in schizophrenia. Schizophr Res 147(2-3):393–397
De Bartolomeis A, Fiore G et al (2005) Dopamine-glutamate interaction and antipsychotics mechanism of action: implication for new pharmacological strategies in psychosis. Curr Pharm Des 11(27):3561–3594
De Cagna F, Fusar-Poli L et al (2019) The role of intranasal oxytocin in anxiety and depressive disorders: a systematic review of randomized controlled trials. Clin Psychopharmacol Neurosci 17(1):1
De Coster L, Lin L et al (2019) Neural and behavioral effects of oxytocin administration during theory of mind in schizophrenia and controls: a randomized control trial. Neuropsychopharmacology 44(11):1925–1931
Del Razo RA, Berger T et al (2020) Effects of chronic intranasal oxytocin on behavior and cerebral glucose uptake in juvenile titi monkeys. Psychoneuroendocrinology 113:104494
Demirci E, Ozmen S et al (2016) The relationship between aggression, empathy skills and serum oxytocin levels in male children and adolescents with attention deficit and hyperactivity disorder. Behav Pharmacol 27(8):681–688
Devost D, Girotti M et al (2005) Oxytocin induces dephosphorylation of eukaryotic elongation factor 2 in human myometrial cells. Endocrinology 146(5):2265–2270
Domes G, Kumbier E et al (2014) Oxytocin promotes facial emotion recognition and amygdala reactivity in adults with Asperger syndrome. Neuropsychopharmacology 39(3):698–706
D'Sa C, Duman RS (2002) Antidepressants and neuroplasticity. Bipolar Disord 4(3):183–194
Durham PL (2004) CGRP-receptor antagonists—a fresh approach to migraine therapy? N Engl J Med 350(11):1073–1075
Duric V, Banasr M et al (2010) A negative regulator of MAP kinase causes depressive behavior. Nat Med 16(11):1328–1332
Edition F (2013) Diagnostic and statistical manual of mental disorders. Am Psychiatric Assoc 21:591–643
Eliava M, Melchior M et al (2016) A new population of parvocellular oxytocin neurons controlling magnocellular neuron activity and inflammatory pain processing. Neuron 89(6):1291–1304
Erbaş O, Oltulu F et al (2012) Amelioration of rotenone-induced dopaminergic cell death in the striatum by oxytocin treatment. Peptides 38(2):312–317
Erbas O, Oltulu F et al (2013a) Suppression of exaggerated neuronal oscillations by oxytocin in a rat model of Parkinson’s disease. Gen Physiol Biophys 32(4):517–525
Erbas O, Yılmaz M et al (2013b) Oxytocin inhibits pentylentetrazol-induced seizures in the rat. Peptides 40:141–144
Erfanparast A, Tamaddonfard E et al (2017) Intra-hippocampal microinjection of oxytocin produced antiepileptic effect on the pentylenetetrazol-induced epilepsy in rats. Pharmacol Rep 69(4):757–763
Ernst C, Olson AK et al (2006) Antidepressant effects of exercise: evidence for an adult-neurogenesis hypothesis? J Psychiatry Neurosci 31(2):84–92
Feeser M, Fan Y et al (2015) Oxytocin improves mentalizing–pronounced effects for individuals with attenuated ability to empathize. Psychoneuroendocrinology 53:223–232
Feifel D, MacDonald K et al (2010) Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients. Biol Psychiatry 68(7):678–680
Feifel D, Shilling PD et al (2012) The effects of oxytocin and its analog, carbetocin, on genetic deficits in sensorimotor gating. Eur Neuropsychopharmacol 22(5):374–378
Feifel D, Shilling PD et al (2016) A review of oxytocin’s effects on the positive, negative, and cognitive domains of schizophrenia. Biol Psychiatry 79(3):222–233
Ferretti V, Maltese F et al (2019) Oxytocin signaling in the central amygdala modulates emotion discrimination in mice. Curr Biol 29(12):1938-1953. e1936
Ford CL, Young LJ (2020) Translational opportunities for circuit-based social neuroscience: advancing 21st century psychiatry. Curr Opin Neurobiol 68:1–8
Fuxe K, Borroto-Escuela DO et al (2012) On the role of volume transmission and receptor–receptor interactions in social behaviour: focus on central catecholamine and oxytocin neurons. Brain Res 1476:119–131
Gamal-Eltrabily M, Manzano-García A (2018) Role of central oxytocin and dopamine systems in nociception and their possible interactions: suggested hypotheses. Rev Neurosci 29(4):377–386
Gibson CM, Penn DL et al (2014) A pilot six-week randomized controlled trial of oxytocin on social cognition and social skills in schizophrenia. Schizophr Res 156(2-3):261–265
Gimpl G, Fahrenholz F (2001) The oxytocin receptor system: structure, function, and regulation. Physiol Rev 81(2):629–683
Gordon I, Jack A et al (2016) Intranasal oxytocin enhances connectivity in the neural circuitry supporting social motivation and social perception in children with autism. Sci Rep 6(1):35054
Graustella AJ, MacLeod C (2012) A critical review of the influence of oxytocin nasal spray on social cognition in humans: evidence and future directions. Horm Behav 61(3):410–418
Green L, Fein D et al (2001) Oxytocin and autistic disorder: alterations in peptide forms. Biol Psychiatry 50(8):609–613
Griffin GD, Ferri-Kolwicz SL et al (2010) Ovarian hormone-induced reorganization of oxytocin-labeled dendrites and synapses lateral to the hypothalamic ventromedial nucleus in female rats. J Comp Neurol 518(22):4531–4545
Grinevich V, Neumann ID (2020) Brain oxytocin: how puzzle stones from animal studies translate into psychiatry. Mol Psychiatry:1–15
Guastella AJ, Einfeld SL et al (2010) Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders. Biol Psychiatry 67(7):692–694
Guoynes C, Simmons T et al (2018) Chronic intranasal oxytocin has dose-dependent effects on central oxytocin and vasopressin systems in prairie voles (Microtus ochrogaster). Neuroscience 369:292–302
Guze SB (1995) Diagnostic and statistical manual of mental disorders, (DSM-IV). Am J Psychiatr 152(8):1228–1228
Hargreaves R, Shepheard S (1999) Pathophysiology of migraine—new insights. Can J Neurol Sci 26(3):12–19
Hay DF, Pawlby S et al (2001) Intellectual problems shown by 11-year-old children whose mothers had postnatal depression. J Child Psychol Psychiatry Allied Discip 42(7):871–889
Heck AL, Sheng JA et al (2020) Social isolation alters hypothalamic pituitary adrenal axis activity after chronic variable stress in male C57BL/6 mice. Stress 23(4):457–465
Heise C, Taha E et al (2017) eEF2K/eEF2 pathway controls the excitation/inhibition balance and susceptibility to epileptic seizures. Cereb Cortex 27(3):2226–2248
Hollander E, Novotny S et al (2003) Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger’s disorders. Neuropsychopharmacology 28(1):193–198
Hollander E, Bartz J et al (2007) Oxytocin increases retention of social cognition in autism. Biol Psychiatry 61(4):498–503
Huang H, Michetti C et al (2014) Chronic and acute intranasal oxytocin produce divergent social effects in mice. Neuropsychopharmacology 39(5):1102–1114
Hurlemann R, Grinevich V (2018) Behavioral pharmacology of neuropeptides: oxytocin. Springer
Husarova VM, Lakatosova S et al (2016) Plasma oxytocin in children with autism and its correlations with behavioral parameters in children and parents. Psychiatry Investig 13(2):174–183
Insel TR, Winslow JT (1991) Central administration of oxytocin modulates the infant rats response to social isolation. Eur J Pharmacol 203(1):149–152
Işık Ü, Bilgiç A et al (2018) Serum levels of cortisol, dehydroepiandrosterone, and oxytocin in children with attention-deficit/hyperactivity disorder combined presentation with and without comorbid conduct disorder. Psychiatry Res 261:212–219
Jakubovski E, Johnson JA et al (2019) Systematic review and meta-analysis: dose-response curve of SSRIs and SNRIs in anxiety disorders. Depression Anxiety 36(3):198–212
Jansen LM, Gispen-de Wied CC et al (2006) Autonomic and neuroendocrine responses to a psychosocial stressor in adults with autistic spectrum disorder. J Autism Dev Disord 36(7):891–899
Ji H, Su W et al (2016) Intranasal oxytocin administration improves depression-like behaviors in adult rats that experienced neonatal maternal deprivation. Behav Pharmacol 27(8):689–696
Jones P, Robinson I (1982) Differential clearance of neurophysin and neurohypophysial peptides from the cerebrospinal fluid in conscious guinea pigs. Neuroendocrinology 34(4):297–302
Jurek B, Slattery DA et al (2012) Differential contribution of hypothalamic MAPK activity to anxiety-like behaviour in virgin and lactating rats. PLoS One 7(5):e37060
Jusiak K, Brudkowska Ż et al (2017) The role of oxytocin in the pathogenesis and treatment of schizophrenia. Curr Probl Psychiatry 18(4):300–312
Kabilan A (2014) Pharmacological role of oxytocin-a short review. J Pharm Sci Res 6(4):220
Kagerbauer SM, Martin J et al (2013) Plasma oxytocin and vasopressin do not predict neuropeptide concentrations in human cerebrospinal fluid. J Neuroendocrinol 25(7):668–673
Kanat M, Heinrichs M et al (2015) Oxytocin attenuates neural reactivity to masked threat cues from the eyes. Neuropsychopharmacology 40(2):287–295
Keverne EB, Kendrick KM (1992) Oxytocin facilitation of maternal behavior in sheep. Ann N Y Acad Sci 652(1):83–101
Khoshneviszadeh M, Rahimian R et al (2016) Oxytocin is involved in the proconvulsant effects of Sildenafil: possible role of CREB. Toxicol Lett 256:44–52
Kikusui T, Winslow JT et al (2006) Social buffering: relief from stress and anxiety. Philosophical Transact R Soc Biol Sci 361(1476):2215–2228
Kim S, Soeken TA et al (2014) Oxytocin and postpartum depression: delivering on what’s known and what's not. Brain Res 1580:219–232
King LB, Walum H et al (2016) Variation in the oxytocin receptor gene predicts brain region-specific expression and social attachment. Biol Psychiatry 80(2):160–169
Kiss A, Mikkelsen JD (2005) Oxytocin-anatomy and functional assignments: a minireview. Endocr Regul 39(3):97
Kistner A, Lhommée E et al (2014) Mechanisms of body weight fluctuations in Parkinson’s disease. Front Neurol 5:84
Koch SB, van Zuiden M et al (2019) Effects of intranasal oxytocin on distraction as emotion regulation strategy in patients with post-traumatic stress disorder. Eur Neuropsychopharmacol 29(2):266–277
Kojić Z, Stojanović D (2013) Pathophysiology of migraine: from molecular to personalized medicine. Med Pregl 66(1-2):53–57
Kowa H, Nakashima K (2012) Cortical spreading depression and molecular genetics in migraine. Rinsho shinkeigaku=. Clin Neurol 52(11):1006–1008
Krendl AC, Perry BL (2021) The impact of sheltering in place during the COVID-19 pandemic on older adults’ social and mental well-being. J Gerontol Series B 76(2):e53–e58
Labuschagne I, Phan KL et al (2010) Oxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorder. Neuropsychopharmacology 35(12):2403–2413
Landgraf R, Neumann ID (2004) Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication. Front Neuroendocrinol 25(3-4):150–176
László K, Kovács A et al (2016) Positive reinforcing effect of oxytocin microinjection in the rat central nucleus of amygdala. Behav Brain Res 296:279–285
Lee M, Scheidweiler K et al (2018) Oxytocin by intranasal and intravenous routes reaches the cerebrospinal fluid in rhesus macaques: determination using a novel oxytocin assay. Mol Psychiatry 23(1):115–122
Lee PR, Brady DL et al (2005) Social interaction deficits caused by chronic phencyclidine administration are reversed by oxytocin. Neuropsychopharmacology 30(10):1883–1894
Leonzino M, Busnelli M et al (2016) The timing of the excitatory-to-inhibitory GABA switch is regulated by the oxytocin receptor via KCC2. Cell Rep 15(1):96–103
Liu W, Pappas GD et al (2005) Oxytocin receptors in brain cortical regions are reduced in haploinsufficient (+/−) reeler mice. Neurol Res 27(4):339–345
Liu Y, Wang Z (2003) Nucleus accumbens oxytocin and dopamine interact to regulate pair bond formation in female prairie voles. Neuroscience 121(3):537–544
Loup F, Tribollet E et al (1991) Localization of high-affinity binding sites for oxytocin and vasopressin in the human brain. An autoradiographic study. Brain Res 555(2):220–232
Ma Y, Shamay-Tsoory S et al (2016) Oxytocin and social adaptation: insights from neuroimaging studies of healthy and clinical populations. Trends Cogn Sci 20(2):133–145
Ma Z, Wang S-J et al (2008) Increased metabolite concentration in migraine rat model by proton MR spectroscopy in vivo and ex vivo. Neurol Sci 29(5):337–342
MacDonald K, Feifel D (2013) Helping oxytocin deliver: considerations in the development of oxytocin-based therapeutics for brain disorders. Front Neurosci 7:35
MacDonald K, MacDonald TM (2010) The peptide that binds: a systematic review of oxytocin and its prosocial effects in humans. Harv Rev Psychiatry 18(1):1–21
Maejima Y, Sakuma K et al (2014) Oxytocinergic circuit from paraventricular and supraoptic nuclei to arcuate POMC neurons in hypothalamus. FEBS Lett 588(23):4404–4412
Magon N, Kalra S (2011) The orgasmic history of oxytocin: love, lust, and labor. Indian J Endocrinol Metabol 15(Suppl3):S156
Malberg JE, Eisch AJ et al (2000) Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20(24):9104–9110
Martins D, Davies C et al (2020) Intranasal oxytocin increases heart-rate variability in men at clinical high risk for psychosis: a proof-of-concept study. Transl Psychiatry 10(1):1–12
Martins D, Paduraru M et al (2021) Heterogeneity in response to repeated intranasal oxytocin in schizophrenia and autism spectrum disorders: a meta-analysis of variance. Br J Pharmacol:1–19
Marxreiter F, Regensburger M et al (2013) Adult neurogenesis in Parkinson’s disease. Cell Mol Life Sci 70(3):459–473
Matsushita H, Matsuzaki M et al (2012) Antidepressant-like effect of sildenafil through oxytocin-dependent cyclic AMP response element-binding protein phosphorylation. Neuroscience 200:13–18
Mayer AV, Wermter A-K et al (2021) Randomized clinical trial shows no substantial modulation of empathy-related neural activation by intranasal oxytocin in autism. Sci Rep 11(1):1–13
McCarthy MM (1990) Oxytocin inhibits infanticide in female house mice (Mus domesticus). Horm Behav 24(3):365–375
McQuaid RJ, McInnis OA et al (2014) Making room for oxytocin in understanding depression. Neurosci Biobehav Rev 45:305–322
Meisenberg G (1982) Short-term behavioural effects of neurohypophyseal hormones: pharmacological characteristics. Neuropharmacology 21(4):309–316
Melby K, Gråwe RW et al (2019) Effect of intranasal oxytocin on alcohol withdrawal syndrome: a randomized placebo-controlled double-blind clinical trial. Drug Alcohol Depend 197:95–101
Melby KGR, Aamo TO, Skovlund E, Spigset O (2021) Efficacy of self-administered intranasal oxytocin on alcohol use and craving after detoxification in patients with alcohol dependence. A double-blind placebo-controlled trial. Alcohol Alcohol 56(5):565–572
Mens WB, Witter A et al (1983) Penetration of neurohypophyseal hormones from plasma into cerebrospinal fluid (CSF): half-times of disappearance of these neuropeptides from CSF. Brain Res 262(1):143–149
Meyer-Lindenberg A, Domes G et al (2011) Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nat Rev Neurosci 12(9):524–538
Modabbernia A, Rezaei F et al (2013) Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia. CNS Drugs 27(1):57–65
Modahl C, Green LA et al (1998) Plasma oxytocin levels in autistic children. Biol Psychiatry 43(4):270–277
Modi ME, Inoue K et al (2015) Melanocortin receptor agonists facilitate oxytocin-dependent partner preference formation in the prairie vole. Neuropsychopharmacology 40(8):1856–1865
Moore K, Hussey E et al (1997) Safety, tolerability, and pharmacokinetics of sumatriptan in healthy subjects following ascending single intranasal doses and multiple intranasal doses. Cephalalgia 17(4):541–550
Mottolese R, Redouté J et al (2014) Switching brain serotonin with oxytocin. Proc Natl Acad Sci 111(23):8637–8642
Murray L, Arteche A et al (2011) Maternal postnatal depression and the development of depression in offspring up to 16 years of age. J Am Acad Child Adolesc Psychiatry 50(5):460–470
O'Connor RC, Wetherall K et al (2021) Mental health and well-being during the COVID-19 pandemic: longitudinal analyses of adults in the UK COVID-19 Mental Health & Wellbeing study. Br J Psychiatry 218(6):326–333
Pagani M, De Felice A et al (2020) Acute and repeated intranasal oxytocin differentially modulate brain-wide functional connectivity. Neuroscience 445:83–94
Passoni I, Leonzino M et al (2016) Carbetocin is a functional selective Gq agonist that does not promote oxytocin receptor recycling after inducing β-Arrestin-independent internalisation. J Neuroendocrinol 28(4)
Pedersen CA, Prange AJ (1979) Induction of maternal behavior in virgin rats after intracerebroventricular administration of oxytocin. Proc Natl Acad Sci 76(12):6661–6665
Pedersen CA, Ascher JA et al (1982) Oxytocin induces maternal behavior in virgin female rats. Science 216(4546):648–650
Pedersen CA, Caldwell JD et al (1994) Oxytocin activates the postpartum onset of rat maternal behavior in the ventral tegmental and medial preoptic areas. Behav Neurosci 108(6):1163
Peters JH, McDougall SJ et al (2008) Oxytocin enhances cranial visceral afferent synaptic transmission to the solitary tract nucleus. J Neurosci 28(45):11731–11740
Pincus D, Kose S et al (2010) Inverse effects of oxytocin on attributing mental activity to others in depressed and healthy subjects: a double-blind placebo controlled FMRI study. Front Psychiatry 1:134
Pollak TA, Drndarski S et al (2018) The blood–brain barrier in psychosis. Lancet Psychiatry 5(1):79–92
Quintana D, Westlye LT et al (2015) Low-dose oxytocin delivered intranasally with Breath Powered device affects social-cognitive behavior: a randomized four-way crossover trial with nasal cavity dimension assessment. Transl Psychiatry 5(7):e602–e602
Quintana DS, Westlye LT et al (2016) Low dose intranasal oxytocin delivered with Breath Powered device dampens amygdala response to emotional stimuli: a peripheral effect-controlled within-subjects randomized dose-response fMRI trial. Psychoneuroendocrinology 69:180–188
Quintana DS, Lischke A et al (2021) Advances in the field of intranasal oxytocin research: lessons learned and future directions for clinical research. Mol Psychiatry 26(1):80–91
Rahimian R, Khoshneviszadeh M et al (2020) Oxytocinergic system mediates the proconvulsant effects of sildenafil: the role of calcineurin. Horm Behav 122:104753
Reversi A, Rimoldi V et al (2005) The oxytocin receptor antagonist atosiban inhibits cell growth via a “biased agonist” mechanism. J Biol Chem 280(16):16311–16318
Riem MM, Van Ijzendoorn MH et al (2012) No laughing matter: intranasal oxytocin administration changes functional brain connectivity during exposure to infant laughter. Neuropsychopharmacology 37(5):1257–1266
Riem MM, Kunst LE et al (2020) Intranasal oxytocin enhances stress-protective effects of social support in women with negative childhood experiences during a virtual Trier social stress test. Psychoneuroendocrinology 111:104482
Ross AP, McCann KE et al (2019) Sex-dependent effects of social isolation on the regulation of arginine-vasopressin (AVP) V1a, oxytocin (OT) and serotonin (5HT) 1a receptor binding and aggression. Horm Behav 116:104578
Rung JM, Horta M et al (2021) Safety and tolerability of chronic intranasal oxytocin in older men: results from a randomized controlled trial. Psychopharmacology 238:2405–2418
Sabino AD, Chagas MHN et al (2020) Acute effects of oxytocin in music performance anxiety: a crossover, randomized, placebo-controlled trial. Psychopharmacology 237(6):1757–1767
Sances G, Granella F et al (2003) Course of migraine during pregnancy and postpartum: a prospective study. Cephalalgia 23(3):197–205
Sances G, Tassorelli C et al (2004) Reliability of the nitroglycerin provocative test in the diagnosis of neurovascular headaches. Cephalalgia 24(2):110–119
Schipper NG, Verhoef JC et al (1991) The nasal mucociliary clearance: relevance to nasal drug delivery. Pharm Res 8(7):807–814
Scott BW, Wojtowicz JM et al (2000) Neurogenesis in the dentate gyrus of the rat following electroconvulsive shock seizures. Exp Neurol 165(2):231–236
Shilling PD, Feifel D (2016) Potential of oxytocin in the treatment of schizophrenia. CNS Drugs 30(3):193–208
Shin MS, Ko IG et al (2010) Vardenafil enhances oxytocin expression in the paraventricular nucleus without sexual stimulation. Int Neurourol J 14(4):213
Sikich L, Kolevzon A et al (2021) Intranasal oxytocin in children and adolescents with autism spectrum disorder. N Engl J Med 385(16):1462–1473
Siu MT, Goodman SJ et al (2021) DNA Methylation of the Oxytocin Receptor Across Neurodevelopmental Disorders. J Autism Dev Disord 51:3610–3623
Son SJ, Filosa JA et al (2013) Dendritic peptide release mediates interpopulation crosstalk between neurosecretory and preautonomic networks. Neuron 78(6):1036–1049
Souza RP, Ismail P et al (2010) Variants in the oxytocin gene and risk for schizophrenia. Schizophr Res 121(1-3):279–280
Sun J, Nan G (2016) The mitogen-activated protein kinase (MAPK) signaling pathway as a discovery target in stroke. J Mol Neurosci 59(1):90–98
Sweeney MD, Sagare AP et al (2018) Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol 14(3):133–150
Tanaka A, Furubayashi T et al (2018) Delivery of oxytocin to the brain for the treatment of autism spectrum disorder by nasal application. Mol Pharm 15(3):1105–1111
Tomizawa K, Iga N et al (2003) Oxytocin improves long-lasting spatial memory during motherhood through MAP kinase cascade. Nat Neurosci 6(4):384–390
Troncy E, Morin V et al (2008) Evidence for non-linear pharmacokinetics of oxytocin in anesthetizetized rat. J Pharm Pharm Sci 11(4):12–24
Tsai T-Y, Tseng H-H et al (2019) The interaction of oxytocin and social support, loneliness, and cortisol level in major depression. Clin Psychopharmacol Neurosci 17(4):487
Tzabazis A, Kori S et al (2017) Oxytocin and migraine headache. Headache 57:64–75
Vacher C-M, Frétier P et al (2002) Activation by serotonin and noradrenaline of vasopressin and oxytocin expression in the mouse paraventricular and supraoptic nuclei. J Neurosci 22(5):1513–1522
Van Den Burg EH, Stindl J et al (2015) Oxytocin stimulates extracellular Ca 2+ influx through TRPV2 channels in hypothalamic neurons to exert its anxiolytic effects. Neuropsychopharmacology 40(13):2938–2947
Van Leengoed E, Kerker E et al (1987) Inhibition of post-partum maternal behaviour in the rat by injecting an oxytocin antagonist into the cerebral ventricles. J Endocrinol 112(2):275–282
van Zuiden M, Frijling JL et al (2017) Intranasal oxytocin to prevent posttraumatic stress disorder symptoms: a randomized controlled trial in emergency department patients. Biol Psychiatry 81(12):1030–1040
Veening JG, de Jong T et al (2010) Oxytocin-messages via the cerebrospinal fluid: behavioral effects; a review. Physiol Behav 101(2):193–210
Vrachnis N, Malamas FM et al (2011) The oxytocin-oxytocin receptor system and its antagonists as tocolytic agents. Int J Endocrinol 2011
Wang Y-L, Yuan Y et al (2013) The interaction between the oxytocin and pain modulation in headache patients. Neuropeptides 47(2):93–97
Watanabe T, Kuroda M et al (2015) Clinical and neural effects of six-week administration of oxytocin on core symptoms of autism. Brain 138(11):3400–3412
Wei D, Lee D et al (2015) Endocannabinoid signaling mediates oxytocin-driven social reward. Proc Natl Acad Sci 112(45):14084–14089
Willmore LJ (2005) Antiepileptic drugs and neuroprotection: current status and future roles. Epilepsy Behav 7:25–28
Winter J, Meyer M et al (2021) Chronic oxytocin-driven alternative splicing of CRFR2α induces anxiety. Mol Psychiatry:1–14
Winton-Brown TT, Fusar-Poli P et al (2014) Dopaminergic basis of salience dysregulation in psychosis. Trends Neurosci 37(2):85–94
Wong JC, Shapiro L et al (2021) Nanoparticle encapsulated oxytocin increases resistance to induced seizures and restores social behavior in Scn1a-derived epilepsy. Neurobiol Dis 147:105147
Xiao L, Priest MF et al (2017) Biased oxytocinergic modulation of midbrain dopamine systems. Neuron 95(2):368-384. e365
Yamasue H, Okada T et al (2020) Effect of intranasal oxytocin on the core social symptoms of autism spectrum disorder: a randomized clinical trial. Mol Psychiatry 25(8):1849–1858
Ye X, Shin B-C et al (2021) Developing brain glucose transporters, serotonin, serotonin transporter, and oxytocin receptor expression in response to early-life hypocaloric and hypercaloric dietary, and air pollutant exposures. Dev Neurosci 43(1):27–42
Yeomans DC, Hanson LR et al (2021) Nasal oxytocin for the treatment of psychiatric disorders and pain: achieving meaningful brain concentrations. Transl Psychiatry 11(1):1–10
Zaninetti M, Raggenbass M (2000) Oxytocin receptor agonists enhance inhibitory synaptic transmission in the rat hippocampus by activating interneurons in stratum pyramidale. Eur J Neurosci 12(11):3975–3984
Zhang Z, Klyachko V et al (2007) Blockade of phosphodiesterase type 5 enhances rat neurohypophysial excitability and electrically evoked oxytocin release. J Physiol 584(1):137–147
Financial Support
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Conflict of Interest
None.
Declarations of Interest
None.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Ghazy, A.A., Soliman, O.A., Elbahnasi, A.I., Alawy, A.Y., Mansour, A.M., Gowayed, M.A. (2022). Role of Oxytocin in Different Neuropsychiatric, Neurodegenerative, and Neurodevelopmental Disorders. In: Pedersen, S.H.F. (eds) Reviews of Physiology, Biochemistry and Pharmacology. Reviews of Physiology, Biochemistry and Pharmacology, vol 186. Springer, Cham. https://doi.org/10.1007/112_2022_72
Download citation
DOI: https://doi.org/10.1007/112_2022_72
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-25627-1
Online ISBN: 978-3-031-25628-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)